about
Lack of localization of 5-HT6 receptors on cholinergic neurons: implication of multiple neurotransmitter systems in 5-HT6 receptor-mediated acetylcholine releaseOligomeric amyloid beta associates with postsynaptic densities and correlates with excitatory synapse loss near senile plaquesTechniques for brain imaging in vivo.Age-dependent cerebrovascular dysfunction in a transgenic mouse model of cerebral amyloid angiopathy.Curcumin labels amyloid pathology in vivo, disrupts existing plaques, and partially restores distorted neurites in an Alzheimer mouse model.Specific serotonergic denervation affects tau pathology and cognition without altering senile plaques deposition in APP/PS1 mice.Central proliferation and neurogenesis is impaired in type 2 diabetes and prediabetes animal models.Rapid appearance and local toxicity of amyloid-beta plaques in a mouse model of Alzheimer's diseaseIncreased Spontaneous Central Bleeding and Cognition Impairment in APP/PS1 Mice with Poorly Controlled Diabetes Mellitus.Human tau increases amyloid β plaque size but not amyloid β-mediated synapse loss in a novel mouse model of Alzheimer's disease.Intranasal insulin reverts central pathology and cognitive impairment in diabetic mother offspringCognitive Impairment and Brain and Peripheral Alterations in a Murine Model of Intraventricular Hemorrhage in the Preterm Newborn.Long-Term Mangiferin Extract Treatment Improves Central Pathology and Cognitive Deficits in APP/PS1 Mice.Rapid β-amyloid deposition and cognitive impairment after cholinergic denervation in APP/PS1 mice.Mango leaf extract improves central pathology and cognitive impairment in a type 2 diabetes mouse model.Progressive Neuronal Pathology and Synaptic Loss Induced by Prediabetes and Type 2 Diabetes in a Mouse Model of Alzheimer's Disease.Matrix metalloproteinase inhibition reduces oxidative stress associated with cerebral amyloid angiopathy in vivo in transgenic miceFour-dimensional microglia response to anti-Aβ treatment in APP/PS1xCX3CR1/GFP mice.Rapid microglial response around amyloid pathology after systemic anti-Abeta antibody administration in PDAPP mice.Effect of selective cholinergic denervation on the serotonergic system: implications for learning and memory.Prediabetes and type 2 diabetes implication in central proliferation and neurogenesis.Triflusal reduces dense-core plaque load, associated axonal alterations and inflammatory changes, and rescues cognition in a transgenic mouse model of Alzheimer's disease.Altered NCAM expression associated with the cholinergic system in Alzheimer's disease.GABA(A) receptor antagonists enhance cortical acetylcholine release induced by 5-HT(3) receptor blockade in freely moving rats.Flumazenil and tacrine increase the effectiveness of ondansetron on scopolamine-induced impairment of spatial learning in rats.Low-voltage pattern and absence of sleep-wake cycles are associated with severe hemorrhage and death in very preterm infants.Differential involvement of 5-HT(1B/1D) and 5-HT6 receptors in cognitive and non-cognitive symptoms in Alzheimer's disease.Facilitation of cholinergic transmission by combined treatment of ondansetron with flumazenil after cortical cholinergic deafferentation.Evaluation of cholinergic markers in Alzheimer's disease and in a model of cholinergic deficit.Cholinergic-serotonergic imbalance contributes to cognitive and behavioral symptoms in Alzheimer's disease.Differential central pathology and cognitive impairment in pre-diabetic and diabetic mice.Involvement of an altered 5-HT -{6} receptor function in behavioral symptoms of Alzheimer's disease.Involvement of the GABAergic system in depressive symptoms of Alzheimer's disease.Long-term central pathology and cognitive impairment are exacerbated in a mixed model of Alzheimer's disease and type 2 diabetes.Central vascular disease and exacerbated pathology in a mixed model of type 2 diabetes and Alzheimer's disease.Kinetics of cerebral amyloid angiopathy progression in a transgenic mouse model of Alzheimer disease.Selective effects of the APOE epsilon4 allele on presynaptic cholinergic markers in the neocortex of Alzheimer's disease.Antidiabetic Polypill Improves Central Pathology and Cognitive Impairment in a Mixed Model of Alzheimer's Disease and Type 2 Diabetes.Antibody-mediated clearance of amyloid-beta peptide from cerebral amyloid angiopathy revealed by quantitative in vivo imaging.Characterization of amyloid deposition in the APPswe/PS1dE9 mouse model of Alzheimer disease.
P50
Q28575664-FCFD5158-3DE3-4D86-B3D2-9C6AEF5FCDD1Q30486499-70D7CD3C-D01D-4E80-BAF2-FC66CA2C2843Q30985447-1888B154-9DF8-4DD4-B838-DE3F49A6E757Q33291163-689CCF80-9107-45B8-BCE4-BBA5F4398B6AQ34579152-C4AB0205-CA8D-420F-98DB-3C6193667B92Q35053378-64C826FE-196B-4357-BFB9-C99609053BF1Q35106896-F1C7A917-1C72-44A5-B508-C53C71AA9247Q35689983-3A101612-EC0D-41B6-9B14-87A6C7FBBBE9Q36772914-FC60721E-1A71-4F2E-BA49-DBB02CBBF78CQ37561154-DEDA1CA2-0293-403E-A685-2A0109B2F56AQ38646201-D97ABAC8-F99A-4A99-BC25-1AC215C4110FQ38654119-57DC557C-F3A0-4B39-87B3-02ED4955A327Q38839191-535B516D-51CF-412A-B399-CF7EDF50227EQ39460000-43E06DF4-7554-442A-9391-51D55B822AB8Q39478082-7B7E04E3-9594-4113-B1EC-4D6A4C348984Q39767994-0625B5C0-70E4-43C8-9773-28A8A23485C2Q41230899-560F8F3A-FE94-4ED0-8EB6-6946AB07C374Q41700187-33C6B946-BC22-40AD-9A69-D469BF19BB9DQ42243192-64CB49D2-5D94-4E3B-BF49-E456859C30DEQ42503800-B15908D6-E8D3-4610-8D7F-1845FDD7FE24Q42722855-ABE0D28E-3FA2-4EDE-B477-C45F5835C89AQ43098773-4AC9E099-8515-4B40-971B-BA26CB04079BQ43158595-F6B82F71-9ABC-44AA-B850-69C0FB08613EQ44212259-E2236EA0-DE10-4CED-AA7A-76D63E78E5A6Q44502847-EED80BAD-4D28-4AD4-AF5D-174DE5BA63E6Q44622787-0C8BC6B0-5E4C-423F-9934-BD9C56A79D92Q44626972-2F382AA5-A055-462E-8013-E7A6F51D0F7DQ44956213-4C0909DD-506E-43B6-9A86-458665C1E0DEQ45233427-F81C01C8-6DF6-4520-BCDE-EF32775238EAQ45262354-F713D3C4-4F0E-4454-A0F6-AAD6479B78A0Q46396191-C81D86CC-579C-4A22-952D-BFABAEC60888Q46558596-D3D7F098-4075-4713-AC91-B26D34E5968FQ46582617-D0D01115-48A0-4071-96BF-24D0F5873733Q46618385-F2F70D2B-92B1-4F0E-BA0E-371703392950Q46687220-FD2B98EF-84EF-45D2-B567-ECF494478614Q46890582-865407F3-4B80-4470-8892-F6CFB7E79EC8Q46940489-880F90AA-101B-4F4F-AED1-9560FA3E6D9FQ47336486-DBBA8C4C-C13E-494A-922C-7DE41F7BD0F7Q48266976-B45B7880-2148-4FDA-9765-0B9594015FB0Q48400715-35AF443C-7DDF-4FC2-A6B7-1425CD320FB7
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Monica Garcia-Alloza
@ast
Monica Garcia-Alloza
@en
Monica Garcia-Alloza
@es
Monica Garcia-Alloza
@nl
Monica Garcia-Alloza
@sl
type
label
Monica Garcia-Alloza
@ast
Monica Garcia-Alloza
@en
Monica Garcia-Alloza
@es
Monica Garcia-Alloza
@nl
Monica Garcia-Alloza
@sl
altLabel
Mónica García-Alloza
@en
prefLabel
Monica Garcia-Alloza
@ast
Monica Garcia-Alloza
@en
Monica Garcia-Alloza
@es
Monica Garcia-Alloza
@nl
Monica Garcia-Alloza
@sl
P108
P1053
F-3313-2016
P106
P1153
8953968300
P21
P31
P3829
P496
0000-0003-1610-4114